PLAUR and neoplasm: This review has summarized multiple new applications of uPAR as a target in nanoplatforms carrying therapeutic agents, PTT/PDT platforms, oncolytic virotherapy, gene therapy technologies, monoclonal antibody therapy and tumour immunotherapy in recent years.